Equity strategies

FP Carmignac European Leaders

OEICEuropean market
Share Class

GB00BJHPHZ49

A high-conviction, bottom-up European Ex-UK Equity strategy
  • An investment process seeking profitable companies with attractive long-term prospects, built on robust fundamentals and strong business models
  • A high-conviction, low turnover, concentrated portfolio designed to maximise long-term alpha generation
  • A socially responsible approach which includes negative screening, ESG criteria integration, and a low carbon emission approach
Asset Allocation
Equities100 %
Data as of:  31 Mar 2026.
Risk Indicator

1

2

3

4

5

6

7

Lowest risk Highest risk
Recommended Minimum Investment Horizon
5 years
Cumulative Performance since launch
+ 80.4 %
-
+ 16.3 %
+ 16.2 %
+ 7.5 %
From 15/05/2019
To 10/04/2026
Calendar Year Performance 2025
-
-
-
+ 18.2 %
+ 27.1 %
+ 13.9 %
- 14.8 %
+ 13.9 %
+ 6.8 %
+ 5.8 %
Net Asset Value
1.80 £
Asset Under Management
92 M £
Net Equity Exposure31/03/2026
98.2 %
Data as of:  10 Apr 2026.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.

FP Carmignac European Leaders fund performance

Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.

Our monthly comments

Data as of:  31 Mar 2026.
Fund management team
[Management Team] [Author] Denham Mark

Mark DENHAM

Head of Equities, Fund Manager

Market environment

  • European equities lost momentum in March, with the MSCI Europe trading more mixed as volatility picked up.
  • The escalation of geopolitical tensions, notably the conflict in Iran, weighed on sentiment and led to a more cautious market environment.
  • In parallel, the global debate around AI continued to drive dispersion, but its impact remained less pronounced in Europe than in the US.

Performance commentary

  • During the month of March, the fund delivered a negative absolute performance and underperformed its reference indicator.
  • Industrials weighed on performance. Schneider Electric declined amid growing concerns over the European economic outlook and a potential slowdown in activity.
  • Experian and RELX were also pressured by the perception that they could be AI losers, a view we consider unfounded given the strategic value of their proprietary data assets.
  • Healthcare was also a detractor. Several positions including Straumann, Alcon, Argenx, Sartorius and Genmab underperformed despite no material deterioration in fundamentals. We remain confident in these holdings, which we have maintained and selectively reinforced.
  • Finally, the Energy sector delivered strong performance during the month, but our lack of exposure given it does not meet our investment criteria represented a relative drag on performance.
  • On the other hand, our stock selection within Financials was a relative contributor versus the reference indicator.
  • Deutsche Börse delivered positive returns, benefiting from its defensive, earnings‑resilient business model, while Nordnet performed well after reporting a strong operating profit beat and reiterating its medium‑term guidance.
  • Another outlier during an otherwise difficult month was Galderma, which benefited from the complete exit of a consortium of financial sponsors, a move that was positively received by the market.

Outlook strategy

  • In March, we made several portfolio adjustments as new opportunities emerged.
  • We fully exited our position in Novo Nordisk following disappointing data from its next generation weight loss molecule, which we believe increases future competitive and generic risks.
  • We redeployed the capital to significantly increase our position in EssilorLuxottica, after a sharp share price pullback as we believe the market reaction overlooks other important growth drivers.
  • We also reduced exposure to Consumer Staples, amid concerns that rising logistics costs could pressure margins.
  • In this context, we fully exited Beiersdorf and meaningfully trimmed Unilever and L’Oréal.
  • Finally, within Industrials, we initiated a position in Belimo, a beneficiary of data centre infrastructure build out, following a share price pullback triggered by conservative guidance.
  • European quality stocks are oversold and now trade at attractive multiples.
  • The de rating of quality across sectors has occurred despite generally solid earnings delivery, suggesting the recent underperformance has gone beyond what fundamentals justify.
  • This creates an attractive entry point, especially as markets refocus on fundamentals and earnings visibility becomes increasingly valuable.

Performance Overview

Data as of:  10 Apr 2026.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
Morningstar Rating™ :  © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Source: Carmignac at 13/04/2026

FP Carmignac European Leaders Portfolio overview

Below is an overview of the composition of the portfolio.

Geographical Breakdown

Data as of:  31 Mar 2026.
Europe100.0 %
View details

Key figures

Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.

Exposure Data

Data as of:  31 Mar 2026.
Equity Investment Weight100.0 %
Net Equity Exposure98.2 %
Number of Equity Issuers43
Active Share81.7 %

The strategy in a nutshell

Discover the Fund’s main features and benefits through the words of the Fund Manager.
Fund Management Team
[Management Team] [Author] Denham Mark

Mark DENHAM

Head of Equities, Fund Manager
In our approach to European equities, we focus on sustainable high-quality companies which demonstrate high levels of profitability while favoring profits reinvestment over profits distribution to grow the business for the future.
View Fund's characteristics

Articles that may interest you

Our views9 December 2025English

Down but not out: Why quality growth is poised for a European comeback

6 minute(s) read
Find out more
Strategies insights14 July 2025English

FP Carmignac European Leaders: Letter from the Fund Manager - Q2 2025

3 minute(s) read
Find out more
Strategies insights7 July 2025English

Banking on (non-traditional) financials

5 minute(s) read
Find out more
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
​The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performance is shown net of fees (excluding any subscription fees payable to the distributor). Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.